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Abstract: Background: Cystic fibrosis (CF) lung disease is characterized by an infiltration of activated neutrophils. Oxi-
dative radical formation and neutrophil proteases may interact with the components of CF airway secretions. This study 
examined the soluble factors in CF airway secretions (sol) and determined their effect on the production of superoxide 
radicals. 
Methods: Neutrophils were isolated from three normal subjects. Each preparation of neutrophils can be used in several 
experiments on the same day of preparation. Using a standardized cytochrome c reduction method, the effect of pooled 
CF sol isolated from nine CF patients, on neutrophil superoxide production was studied. 
Results: CF sol phase significantly attenuates the production of superoxide by phorbol stimulated control neutrophils in a 
time and concentration dependent manner. When CF sol is boiled, the inhibitory effect on superoxide was reversed. CF 
soluble heat labile factors clearly attenuated superoxide production, independent of elastase concentration. We conclude 
that the presence of heat labile soluble factors in CF sputum, serve to attenuate superoxide production by human neutro-
phils. 
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INTRODUCTION 
  Cystic Fibrosis (CF) a common genetic disorder, is char-
acterized by chronic bronchiectasis and chronic lung infec-
tions typically associated with Pseudomonas aeruginosa. 
The inflammatory lung disease of Cystic Fibrosis involves 
an accumulation of polymorphonuclear neutrophils (pmns) 
in the large and small airways. When activated, neutrophils 
infiltrate the lung and produce oxygen radicals and prote-
ases, with superoxide as one significant product. The produc-
tion of superoxide and its interaction with factors present in 
the CF airway may be a major determinant of lung injury in 
the disease. Oxygen radicals can cause cellular damage by 
membrane lipid peroxidation and protein sulfhydryl oxida-
tion, leading to anti-protease inactivation and strand breaks 
in nucleic acids [1, 2]. CF sputum contains high quantities of 
cytokines and mediators such as leukotriene LTB4 and IL-8, 
as well as elastase [3, 4]. We hypothesized that soluble fac-
tors in CF airway secretions may alter the production of su-
peroxide by neutrophils. This in turn may contribute to in-
creased bacterial growth, and the associated lung injury in 
the disease. The aim of this study was to describe the effect 
of the soluble phase of CF airway secretions on the produc-
tion of superoxide anion. 
MATERIALS AND METHODS 
Human Neutrophil Isolation 
  Circulating neutrophils were obtained from normal 
healthy volunteers (n=3). Following venopuncture, blood   
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was processed by dextran sedimentation, hypotonic lysis of 
contaminating red cells, and fractionation over a step-
gradient of Ficoll-Hypaque to remove contaminating mono-
nuclear cells, using methods previously published [1,5]. 
Yield from this procedure was usually five to six million 
cells per donor with the purity of > 98 %. The isolated pmns 
were kept on ice with occasional gentle agitation to prevent 
aggregation. From each preparation of pmns, multiple ex-
periments could be completed. Blood products were handled 
and disposed of according to guidelines by the institution. 
Kinetic Microplate Assay for Superoxide Production 
  A very sensitive and widely established assay for moni-
toring superoxide generation is the cytochrome c reduction 
assay [5]. The use of this assay was the basis of superoxide 
determination for this study and has been previously de-
scribed in detail [5, 6]. 
  The temperature of the reaction wells was very well con-
trolled to maximize superoxide production. A closed incuba-
tion chamber that maintained microplate at 37°C and a 
Vmax kinetic reader with a plexiglass incubator with a front 
access door were utilized. The temperature variation was 
only +/- 1.0 % under these conditions. 
  Prior to beginning the assay, the 96 well microtiter plate, 
PBS supplemented with 0.9mM CaCl2, 0.5mM Mg Cl2 and 
7.5mM glucose (PBSG) and the 1.5mM cytochrome c solu-
tion were all preincubated to 37°C. Then, just prior to the 
start of the assay, the following reagents were added to each 
well: 0.176 ml PBSG, 0.0125 ml cytochrome c stock, 0.005 
ml of either superoxide dismutase stock solution (60ug/ml) 
or 5ul of sterile water and 50ul of cell suspension. The con-
tents were mixed and equilibrated to 37°C for two minutes. 
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for at least 5 minutes. When the added factors such as sol 
were added, they were pre-incubated with the pmns for 
specified time periods. Superoxide production was measured 
in the presence of the factor being tested. 
  The results were expressed by plotting the mOD/minute 
change versus time. Control was set to 100% and samples 
with added sol were then compared to control and expressed 
as a percentage. The established assay was a sensitive and 
specific way to measure rates of PMA and FMLP induced 
superoxide production, as described in further detail by 
Mayo and Curnutte [5]. 
Isolation of Sol and Biochemical Analysis 
  Fresh sputum was collected from Cystic Fibrosis patients 
(n=9) and kept on ice during the collection. A minimum of 
10 ml was collected in a sterile container. The sputum was 
then centrifuged at 90,000g for 90 minutes at 4°C, to yield a 
clear supernatant described as sol. The sol was pooled (n=9) 
in the experiments, to minimize the effect of any individual 
variability in sol composition that may exist. All patients 
were not acutely ill, non-hospitalized but all the CF patients 
did have chronic Pseudomonas aeruginosa endobronchitis. 
None had colonization with Burkholderia cepacia. Genotype 
information was not available on all patients, however all the 
patients shared the common classic features of moderate to 
severe CF lung disease. 
  The sol layer was saved and utilized in the cytochrome c 
assay. In addition, small aliquots of the pooled sol phase 
from several CF patients were also heat inactivated at 100°C 
for fifteen minutes. These aliquots were used in the assay 
system described and comparison was made to sol-free con-
trols. The inhibitory effect of sol, in the presence of antitryp-
sin (0.1mg/ml) or specific blocking antibody against LTB4 
or mucin component, alginate (50ug/ml), was also studied. 
Statistical Analysis 
  Student’s t test was used. A p value of <0.5 was consid-
ered significant. 
RESULTS 
CF Sol and Neutrophil Superoxide Production 
  Our results show that the addition of CF sol phase sig-
nificantly attenuates the production of superoxide by phorbol 
stimulated control neutrophils. This was a consistent result 
of several experiments, using three different preparations of 
control pmns and pooled sol preparations from nine CF pa-
tients. The inhibitory effect of CF sol is concentration and 
time dependent. The length of neutrophil pre-incubation of 
9.4 ug/ml CF sol protein was directly related to the extent of 
inhibition of neutrophil superoxide production, or its in-
creased consumption. The thirty minute incubation lowered 
the mOD/min readings by 83 +/- 7% % compared to control 
(100% +/-0) (p< 0.05). This was a consistent result of several 
experiments. 
    The decrease in superoxide dependent cytochrome c 
reduction was fully inhibitable by superoxide dismutase, thus 
verifying that this reduction reaction was due to the presence 
of superoxide. 
 
Dose Dependent Inhibition of Superoxide Production by 
Sol 
  When the CF sol phase was added to the reaction mixture 
in concentrations ranging from 0 to 150ug/ml of protein, 
while keeping PMA concentration constant, the dose-
dependent inhibition of superoxide production by CF sol is 
clearly demonstrated (Fig. 1, p<0.05). This was a consistent 
result of four separate experiments. Furthermore, this at-
tenuation is also seen with receptor mediated agonist, FMLP. 
Pre-incubation of neutrophils with CF sol results in the re-
duction of superoxide production at all concentrations of 
FMLP used. 
 
Fig. (1). The dose dependent inhibition of superoxide production by 
CF sol protein is shown, error bars indicate standard deviation from 
the mean, p<0.05. 
Heat Inactivation, Antitrypsin and a Cellfree System 
  The factors responsible for this downregulation of super-
oxide production appear to be unrelated to the presence of 
elastase in the sol. If 150ug/ml of sol protein and 1-
antitrypsin (0.1mg/ml) in 100 fold excess, was added to each 
reaction mixture, the inhibition of superoxide production is 
not reversed. This would suggest that the attenuating effect 
of sol on free oxygen radical production is not related to the 
enzymatic cleavage of receptor sites by proteases such as 
elastase. Furthermore, characterization of the factor(s) in CF 
sol suggest that they are heat labile. When CF sol is boiled, 
the inhibitory effect on superoxide production is reversed 
(Fig. 2, p<0.05). CF sol does not appear to be cytotoxic since 
trypan blue exclusion was similar in control and treated 
pmns (data not shown). The xanthine/xanthine oxidase assay 
was used to generate superoxide in a cell free system. CF sol 
addition to this cell free assay did not change the superoxide 
production compared to control, thus demonstrating that sol 
does not act as a scavenger for superoxide (p=ns). The in-
hibitory effect of sol, in the presence of antitrypsin 
(0.1mg/ml) or specific blocking antibody against LTB4 or 
mucin component, alginate (50ug/ml), was also studied, and 
no effect on superoxide production was noted. 
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Fig. (2). The inhibitory effect of CF sol is reversed by boiling (115 
+/- 40% v.12 +/-3%, p<0.05). The effect of added sol is unchanged 
by addition of anti-protease (p = ns). 
DISCUSSION 
   This study was conducted to describe the effect of the 
soluble phase of CF airway secretions on the production of 
superoxide radicals. Our results show that there are heat la-
bile factor(s) in the sol phase of CF sputum which can at-
tenuate the production of superoxide by stimulated human 
neutrophils. Upon further characterization, the factor appears 
not to be elastase, since the pre-incubation with anti-protease 
in excess to neutralize elastase did not reverse the sol effect. 
The sol does not appear to have a cytotoxic effect, and does 
not act as a direct scavenger of superoxide, as shown by the 
trypan blue and xanthine oxidase experiments performed. 
Preliminary characterization of possible factors indicated 
that alginate, a major polysaccharide component of mucin, 
has no effect on superoxide production in the assay system 
studied. The use of anti-LTB4 as a blocking antibody to po-
tent inflammatory agent, LTB4, also had no effect. This may 
effect may be found in other obstructive lung diseases, such 
as COPD, since the role of neutrophil based lung damage. 
The study of COPD was beyond the scope of this study. In 
addition, the experiments utilitzed pmns from normal healthy 
controls, since the literature on this assay support this use. 
Further study of CF neutrophils may be warranted. It is not 
clear however in the literature if CF neutrophils are defec-
tive. 
  The genetic defect identified in CF leads to hypersecre-
tion of thick mucus by the mucus glands and submucosal 
glands in the upper and lower airways which can lead to ob-
structive lung disease. CF sputum has been shown to have 
chemotactic activity for neutrophils [7-10]. Kharazmi et al. 
have shown that CF sputum, particularly the sol phase, can 
prime healthy neutrophils to generate a three to five fold 
increase in chemiluminescence in response to FMLP [11]. It 
was suggested that since priming activity was resistant to 
heating the sol phase to 100°C for fifteen minutes, the effect 
on the respiratory burst was due to immune complexes and 
endotoxins. 
  The Cystic Fibrosis Transmembrane Conductance regula-
tor protein (CFTR) a cAMP dependent channel, is the gene 
product identified in the disease [12]. CFTR may play a role 
in the regulation of superoxide production. CFTR is ex-
pressed in neutrophils and mutant CFTR may alter normal 
pmn functioning. The activation of chloride channels may 
influence production of oxygen radicals in stimulated pmns. 
Since the major defect known in Cystic Fibrosis is dimin-
ished chloride conductance through the CFTR channel, it is 
possible that previous reports of altered superoxide produc-
tion in CF neutrophils which express a mutant CFTR protein 
may be related to altered chloride flux [13]. 
  The studies of other groups measuring reactive oxygen 
radicals by the luminol method were completed prior to the 
identification of the CF gene. The CFTR protein which is 
defective in CF is a cAMP dependent chloride channel. Re-
ports have suggested many other roles for CFTR including 
the regulation of endocytic trafficking, organelle acidifica-
tion and an alteration of glycosylation of secreted products, 
such as mucin [14-16]. Its possible role in oxygen radical 
formation has yet to be studied. The host-defense mecha-
nisms of Cystic Fibrosis patients may be impaired and con-
tribute to the acute and progressive lung injury associated 
with the disease [17]. Oxygen radicals are potent defenses 
against bacterial infection, but can simultanously cause 
cross-linking of membrane and intracellular proteins, per-
oxidative changes in membrane lipids and DNA damage. In 
CF patients oxygen free radical generation from activated 
neutrophils can contribute to chronic lung inflammation. 
Pancreatic insufficiency in these patients leads to severe de-
ficiencies in fat-soluble antioxidants, such as vitamin E and 
carotenoids, resulting in impaired antioxidant production. 
The overproduction of superoxide and the underrepresenta-
tion of antioxidants results in an imbalance favoring oxidant 
mediated lung injury [18]. The chronic presence of Pseudo-
monas aeruginosa in the airway results in reactive oxygen 
species and proteolytic enzyme release [19]. The 1- anti-
protease (1-PI) levels in CF patients and controls are simi-
lar [20], however the large increase in pmn elastase in the 
respiratory tract of these patients may negate the neutraliza-
tion capacity of this proteinase inhibitor. There is also evi-
dence that 95% of neutrophil elastase in CF bronchoalveolar 
lavage fluid is not complexed to 1-PI. The formation of the 
complex may be defective and due to inactivation of lipid 
peroxidation [21, 22]. A recent study has shown that neutro-
phils derived from CF patients generate higher levels of su-
peroxide anion than controls [23]. This finding highlights 
further the possible importance of the sol and neutrophil in-
teraction in patients. Our study demonstrates that CF sol con-
tains substances that can alter the normal functioning of neu-
trophils and thus may contribute to the bacterial colonization 
in the CF airway. Further studies will be performed to fur-
ther identify the precise factors responsible for this observa-
tion and isolation of the attenuating factors potentially could 
serve as therapeutic targets. 
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